METTL3 and acute respiratory distress syndrome: ALI/ARDS: Early METTL3 inhibition combined with anti-NETs or anti-ferroptotic agents may stabilize epithelial/endothelial barriers; pharmacodynamic readouts should track barrier repair and m6A-site signatures.